Industry News
Bio-IT hot topic at upcoming seminars
Research firm IDC is to host two breakfast briefings on the bio-IT industry, with a particular focus on Australia and the Asia-Pacific. [ + ]
South Africans quick to pick up Iatia technology
Iatia's QPe phase imaging technology proved popular at the recent International Congress on Electron Microscopy in Durban, South Africa, according to CEO Brian Powell. [ + ]
Pi2 heads for the great outdoors
Sydney-based company Pi2 Limited has touted a new business strategy with two acquisitions, one in life sciences and the other in outdoor advertising. [ + ]
AstraZeneca plans for growth in Qld natural products centre
Pharmaceutical company AstraZeneca plans to augment the Queensland-based natural product research centre in which it has invested $55 million since 1993. [ + ]
Ellex boosts scientific advisory board
Ellex Medical Lasers has boosted its scientific advisory board with the appointment Prof John Marshall, an international expert in ophthalmologic lasers, and Peter Falzon, the former director of business development at US-based laser device company Lumanis. [ + ]
Protein discovery aids neurone research
Australian researchers have unravelled part of the process controlling the production of new neurones from stem cells in the brain. [ + ]
ResMed takes action against US firm in patent battle
Australian sleep apnoea devices company ResMed has filed a lawsuit against US-based Respironics, claiming that several Respironics products infringe on ResMed patents. [ + ]
Biota braces for showdown with 'corporate rationaliser'
The scene has been set for a possible showdown next month between the board of drug discovery company Biota Holdings and Perth businessman Farooq Khan. [ + ]
Benitec, Ozgene team up to build a better rat model
A potentially lucrative bid to provide the drug industry with improved testing capabilities on animal models has been launched by two Australian biotechs. [ + ]
Cardia restructures with a little help from Big Pharma
Melbourne-based company Cardia Technologies has wrapped its medical biotech projects into a new wholly-owned subsidiary company, Big Pharma Ltd. [ + ]
Acrux restructures licensing deal
Melbourne pharmaceutical company Acrux has done an IP swap with Soltec Research that will allow both companies to further their development of transdermal and topical therapeutics. [ + ]
Stem cells workshop set down for UNSW
The University of NSW is holding a workshop on stem cells on November 19th for all NSW researchers working with or interested in working with stem cells. [ + ]
Genome of potential bioremediation agent deciphered
Scientists at The Institute for Genomic Research (TIGR) in the US and collaborators elsewhere have deciphered the genome of a metal ion-reducing bacterium, Shewanella oneidensis, that has great potential as a bioremediation agent to remove toxic metals from the environment.
[ + ]New horizons for pSivida
The announcement that pSivida's porous silicon technology, BioSilicon, has shown it can perform diagnostic tests when applied as a skin patch opens up new revenue horizons for the Perth biotech. [ + ]
Mattick resigns from Benitec board
The co-director of Queensland's Institute for Molecular Bioscience>, Prof John Mattick, has resigned from his position on Benitec's board of directors while he is in Germany on a sabbatical. [ + ]
